SUBSCRIBE
SUBSCRIBE

Krystle Vermes

Business
Top 25 Women Leaders in Biotech: Female Execs Paving the Way for Innovation
The Healthcare Technology Report announced on Nov. 3 its list of the Top 25 Women Leaders in Biotechnology of 2020.
November 5, 2020
 · 
2 min read
 · 
Krystle Vermes
Pharm Country
Researchers Discover How Pancreatic Cancer Cells Evade Starvation
A new study suggests that pancreatic cancer cells avoid starvation by signaling to nerves. This encourages them to grow into dense tumors and release the nutrients the cells need to survive.
November 3, 2020
 · 
3 min read
 · 
Krystle Vermes
Drug Development
Regeneron Hits Pause on LUMINA-1 Trial Due to Concerns with Garetosmab
Regeneron announced on Friday that it is pausing dosing of garetosmab (REGN2477), an investigational therapy, in the Phase I LUMINA-1 trial.
November 2, 2020
 · 
3 min read
 · 
Krystle Vermes
Courtesy of joreks/Getty Images
Drug Development
Novo Nordisk Ends Development of NN9828, Shifts Focus to Pandemic Initiatives
Novo Nordisk announced today that it has ended its development of the anti-IL-21 antibody NN9828 in combination with Victoza. The decision was made after analyzing Phase II clinical trial data in patients with Type 1 diabetes.
October 30, 2020
 · 
2 min read
 · 
Krystle Vermes
Deals
Syneos Health to Acquire Synteract, Expand Its Global Expertise
Syneos Health announced on Wednesday that it has agreed to acquire Synteract, a full-service Contract Research Organization (CRO) focused on the biopharmaceutical industry.
October 29, 2020
 · 
3 min read
 · 
Krystle Vermes
Daphne Koller (left) and Mary Rozenman (right)
Business
Insitro and BMS Team Up to Pave the Way for New ALS and FTD Treatments
Through this collaboration, Insitro will utilize its proprietary platform, Insitro Human (ISH), to create induced pluripotent stem cell (iPSC) derived disease models for both diseases.
October 28, 2020
 · 
3 min read
 · 
Krystle Vermes
Photo courtesy of Exact Sciences
Deals
Exact Sciences to Acquire Thrive in Deal Valued at $2.15 Billion
The deal, which is worth up to $2.15 billion, is expected to close in the first quarter of 2021 and is subject to regulatory approval.
October 27, 2020
 · 
3 min read
 · 
Krystle Vermes
Policy
Spectrum Pharmaceuticals Sees Delay from FDA on Eflapegrastim BLA
“We are actively working with the FDA to find a way to expedite the plant inspection,” said Joe Turgeon, president and CEO of Spectrum Pharmaceuticals. “The manufacturing facility is ready for inspection and we are eager to assist the FDA in completing their assessment as soon as possible.”
October 26, 2020
 · 
3 min read
 · 
Krystle Vermes
Photo courtesy of Arixa Pharmaceuticals
Deals
Could Arixa Pharmaceuticals’ Lead Product Pave the Way for More Efficient Antibiotics?
Arixa Pharmaceuticals announced on Thursday that Pfizer’s hospital business has agreed to acquire the company. Arixa has been developing oral antibiotics for antibiotic-resistant Gram-negative infections.
October 23, 2020
 · 
3 min read
 · 
Krystle Vermes
JHVEPhoto/Shutterstock
Keytruda Paves the Way for More Effective Classical Hodgkin Lymphoma Treatment
FDA had approved its expanded label for Keytruda. Specifically, the anti-PD-1 therapy’s expanded label was approved for the treatment of relapsed or refractory cHL.
October 21, 2020
 · 
3 min read
 · 
Krystle Vermes
Biogen is planning to cut its Alzheimer's drug Adu
Drug Development
Biogen to Halt Work on Opicinumab, Steer Focus Toward Parkinson’s Disease
Biogen originally announced the initiation of its Phase II clinical trial, AFFINITY, designed to evaluate opicinumab back in 2017. The drug was being examined as an investigational add-on therapy for patients with relapsing MS.
October 21, 2020
 · 
3 min read
 · 
Krystle Vermes
Job Trends
INCOG BioPharma Paves the Way for New Jobs with Expansion in Indiana
INCOG BioPharma Services, is a biopharmaceutical manufacturing services startup that will be establishing a manufacturing plant soon. You can get more details here.
October 20, 2020
 · 
3 min read
 · 
Krystle Vermes
Drs. Elsa Flores, Marco Napoli and their research
Moffitt Cancer Center Sees Breakthrough in Latest Pan-Cancer Analysis
Through their work, they were able to determine that the protein, TAp63, appears to impact the level of RNA molecules within the body. This subsequently connects the activities of p53 and AKT, the altered genes in cancer.
October 20, 2020
 · 
3 min read
 · 
Krystle Vermes
Cynthia S. Goldsmith and A. Tamin/CDC
Pharm Country
The Race for a COVID-19 Vaccine Continues to Heat Up as Case Numbers Rise
Several biopharmaceutical companies have made headway as of late in the race to develop a vaccine for COVID-19, which is responsible for the current global pandemic.
October 15, 2020
 · 
3 min read
 · 
Krystle Vermes
Aviptadil shows promising results against COVID-19
Business
Relief Therapeutics and NeuroRx Release Promising Data for Potential COVID-19 Treatment Aviptadil
Relief Therapeutics and NeuroRx released results on Tuesday from their open-label prospective study looking into RLF-100 (aviptadil) as a potential treatment for COVID-19 and respiratory failure.
October 14, 2020
 · 
3 min read
 · 
Krystle Vermes
Load More